Topic: Gene Patent

5 IP Issues to Watch in 2014

How to get a better handle on the issues that will shape the intellectual property landscape in the coming year? Read what experts are writing on JD Supra: 1. Patent trolls: The debate over patent trolls – non-practicing entities that file lawsuits in an attempt to collect licensing fees on technologies that they themselves do not… Read more »

JD Supra Corporate Brief: European Cookies, Gene Patents, Reasonable Customers, Liquidity Requirements

Why wait for the holidays? Give yourself a gift today: an email subscription to the JD Supra Corporate Brief. It’s informative, entertaining, and – best of all – comes in your size… Those Europeans sure are particular about their cookies, aren’t they? (Cedric Burton, Christopher Kuner, and Anna Pateraki at Wilson Sonsini) The EEOC just… Read more »

Inevitable? Supreme Court Myriad Ruling Leads to Challenge of Human Stem Cell Patent

When the Supreme Court ruled last month that human genes were not patent eligible, writes attorney Antoinette Konski of Foley & Lardner: “[m]any in the biotech community were relieved that the Supreme Court in Myriad limited its holding of patent-ineligibility to isolated, naturally-occurring genes. However, patent practitioners cautioned that Myriad’s holding could potentially be applied… Read more »

JD Supra Corporate Brief: Fair Working Conditions, WARN Act Notices, Deferred Employee Compensation, Human Gene Patents

It’s Friday, and here at the JD Supra Corporate Brief, that means an extra Danish on the way into the office. Care to join us? How can multinationals ensure fair working conditions for workers on the other side of the globe? (NAVEX Global) The exemption from WARN Act notices for companies in Chapter 11 just… Read more »

IP Law News: Latest Need-to-Know from JD Supra

For your reference, a roundup of recent updates on intellectual property law issues in the news: design patents, the patentability of genetic material, trademark disputes, and more. You should know: On Design Patents… The Future of Design Patents (Sterne Kessler): Attorney Tracy-Gene G. Durkin’s take on what the future may hold for design patents. Is… Read more »

DNA Eligible for Patent Protection, Court Rules in Myriad (Again)

“Isolated DNA molecules are patent-eligible, reaffirmed the U.S. Court of Appeals for the Federal Circuit in Ass’n for Molecular Pathology et al. v. Myriad Genetics, Inc. et al., lifting a cloud of uncertainty over DNA composition patents. ‘The isolated DNA molecules before us are not found in nature. They are obtained in laboratory and are… Read more »